{"name":"Amphivena Therapeutics, Inc.","slug":"amphivena-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"AMV564","genericName":"AMV564","slug":"amv564","indication":"Other","status":"phase_1"},{"name":"AMV564 14-Day CIV","genericName":"AMV564 14-Day CIV","slug":"amv564-14-day-civ","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AMV564","genericName":"AMV564","slug":"amv564","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"AMV564 14-Day CIV","genericName":"AMV564 14-Day CIV","slug":"amv564-14-day-civ","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE52YndCeDNJYXJJLUNOcnFIMkZ3R3lwdzd0MW5ZeGRld1RFeXEycmpCS2xFX0Y1V0JMRUNyNmJtNjlCT2RZLXlXV2JzRjhNam43VzgxNno1djdFVFZHcFpVTWxmaWhPMHVBSnc?oc=5","date":"2024-02-24","type":"trial","source":"Wiley Online Library","summary":"Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors - Wiley Online Library","headline":"Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced sol","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNaVJ4YUFhRDBlRHlyOFp0aFM0VFR5Nl9QbllTd0pyckE0NTVYaFFodkx0dGJlWHlaNEJORDA5QlJRQ1pjc0NoMWFOU1VGTWs4ZzBySUdVY2NiVmg1b3RoXzhtT0tBY1o3VkRpQ3JUU0x6MHNxcGZkd0lXWDNFWjhUalR1elNka0M2TnEzRzBqcXM3QUhZTUhBdUhVbWRBZmtCeHlKQw?oc=5","date":"2022-11-30","type":"pipeline","source":"BioSpace","summary":"Pathios Therapeutics Appoints Jeanmarie Guenot, Ph.D., as Non-Executive Director - BioSpace","headline":"Pathios Therapeutics Appoints Jeanmarie Guenot, Ph.D., as Non-Executive Director","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxPbVNCTHNJRzh0NFVPUmtpMDhjQXBjX003QTRiZ0szZ1JYalFkU3NmYkZ2VU1EZHJadmlmVTBLUTZ5Wldac3I0dHNxVEVSMHR6ZkdCV1llQlUwaURIVlZ4N2x4NHNfMTFLUW1XNzltR3g2VXFGM3B6VExYTVZqYVM3MVBXc194SmNCR0VHZ3F0WFZJT09MZkd2b1FyTmRJY2N4MGoxTG1GU1lELUxhd1llX1R5SEdfZXhmXzhIdzk0MktiTXVBaFozbTBvR2JOTGl1dV8xS0FKa0o5cDFmaVROcDVR?oc=5","date":"2020-12-16","type":"trial","source":"prnewswire.com","summary":"Amphivena Therapeutics Announces First Patient Dosed in the Phase 1 Dose Expansion of AMV564 - prnewswire.com","headline":"Amphivena Therapeutics Announces First Patient Dosed in the Phase 1 Dose Expansion of AMV564","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPbGg1M18ySjBFemF1bl84ODVmcG1KeHRYVHRZLXV3N01ZeUhmVjdwVDVVTV9tMXdQNkpOVUFzMC1kNk1HTE1HU3NEYnFQM293YWxWZXpJVEpuY05KTDVhTUdrMVAyYzF5TWs2LURCZS1DamlJa1pISTlBTU93bnJqaWlXT0VPeUtqYVRBWA?oc=5","date":"2019-09-24","type":"pipeline","source":"Fierce Biotech","summary":"Quiet biotech Amphivena nabs $62M funding round - Fierce Biotech","headline":"Quiet biotech Amphivena nabs $62M funding round","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE9sLS0zSHd2Zk5sYjdnejltTWduQ0tsUmREUkV5U3hFbE54b1Q0ZVlJREI4eTRWck1yRTUwa25TNllZcmJabmthZTVTNGpYMW40bnJXbTJQMDJFTk5HN1pJX21KRHpsOHc4VXpHSldicGpVeTg?oc=5","date":"2015-09-18","type":"pipeline","source":"BioSpace","summary":"The 10 Hottest Bay Area Biotech Startups - BioSpace","headline":"The 10 Hottest Bay Area Biotech Startups","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}